Fig 1.
Flow diagram for the inclusion of the study participants.
Table 1.
Baseline characteristics of the study participants who underwent health screening examination between 2013 and 2014.
Fig 2.
Forest plot on the risk of liver cirrhosis according to the cumulative days of drug uses.
Fig 3.
Restricted cubic splines on the risk of liver cirrhosis according to the cumulative days of drug uses.
(A) Amlodipine use. (B) Atenolol use. (C) Digoxin use. (D) Isosorbide dinitrate use. (E) Telmisartan use. (F) Torasemide use.